Incidence and prevalence of multiple sclerosis in the UK 1990–2010: a descriptive study in the General Practice Research Database

Objectives To estimate the incidence and prevalence of multiple sclerosis (MS) by age and describe secular trends and geographic variations within the UK over the 20-year period between 1990 and 2010 and hence to provide updated information on the impact of MS throughout the UK. Design A descriptive...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of neurology, neurosurgery and psychiatry Ročník 85; číslo 1; s. 76 - 84
Hlavní autoři: Mackenzie, I S, Morant, S V, Bloomfield, G A, MacDonald, T M, O'Riordan, J
Médium: Journal Article
Jazyk:angličtina
Vydáno: England BMJ Publishing Group LTD 01.01.2014
BMJ Publishing Group
Edice:Research paper
Témata:
Adult
Age
Age Factors
Aged
Aged, 80 and over
Databases, Factual
Disease
Female
Follow-Up Studies
General Practice - statistics & numerical data
Geography
Hospitalization - statistics & numerical data
Hospitals
Humans
Incidence
Longitudinal Studies
Male
Middle Aged
Mortality
Multiple Sclerosis
Multiple Sclerosis - epidemiology
Patients
Population
Practice research
Prevalence
Regression analysis
Sex Factors
Treatment Outcome
United Kingdom - epidemiology
Womens health
Young Adult
United Kingdom > UK
England
Wales
Multiple Sclerosis
Epidemiology
ISSN:0022-3050, 1468-330X, 1468-330X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Objectives To estimate the incidence and prevalence of multiple sclerosis (MS) by age and describe secular trends and geographic variations within the UK over the 20-year period between 1990 and 2010 and hence to provide updated information on the impact of MS throughout the UK. Design A descriptive study. Setting The study was carried out in the General Practice Research Database (GPRD), a primary care database representative of the UK population. Main outcome measures Incidence and prevalence of MS per 100 000 population. Secular and geographical trends in incidence and prevalence of MS. Results The prevalence of MS recorded in GPRD increased by about 2.4% per year (95% CI 2.3% to 2.6%) reaching 285.8 per 100 000 in women (95% CI 278.7 to 293.1) and 113.1 per 100 000 in men (95% CI 108.6 to 117.7) by 2010. There was a consistent downward trend in incidence of MS reaching 11.52 per 100 000/year (95% CI 10.96 to 12.11) in women and 4.84 per 100 000/year (95% CI 4.54 to 5.16) in men by 2010. Peak incidence occurred between ages 40 and 50 years and maximum prevalence between ages 55 and 60 years. Women accounted for 72% of prevalent and 71% of incident cases. Scotland had the highest incidence and prevalence rates in the UK. Conclusions We estimate that 126 669 people were living with MS in the UK in 2010 (203.4 per 100 000 population) and that 6003 new cases were diagnosed that year (9.64 per 100 000/year). There is an increasing population living longer with MS, which has important implications for resource allocation for MS in the UK.
AbstractList To estimate the incidence and prevalence of multiple sclerosis (MS) by age and describe secular trends and geographic variations within the UK over the 20-year period between 1990 and 2010 and hence to provide updated information on the impact of MS throughout the UK.OBJECTIVESTo estimate the incidence and prevalence of multiple sclerosis (MS) by age and describe secular trends and geographic variations within the UK over the 20-year period between 1990 and 2010 and hence to provide updated information on the impact of MS throughout the UK.A descriptive study.DESIGNA descriptive study.The study was carried out in the General Practice Research Database (GPRD), a primary care database representative of the UK population.SETTINGThe study was carried out in the General Practice Research Database (GPRD), a primary care database representative of the UK population.Incidence and prevalence of MS per 100 000 population. Secular and geographical trends in incidence and prevalence of MS.MAIN OUTCOME MEASURESIncidence and prevalence of MS per 100 000 population. Secular and geographical trends in incidence and prevalence of MS.The prevalence of MS recorded in GPRD increased by about 2.4% per year (95% CI 2.3% to 2.6%) reaching 285.8 per 100 000 in women (95% CI 278.7 to 293.1) and 113.1 per 100 000 in men (95% CI 108.6 to 117.7) by 2010. There was a consistent downward trend in incidence of MS reaching 11.52 per 100 000/year (95% CI 10.96 to 12.11) in women and 4.84 per 100 000/year (95% CI 4.54 to 5.16) in men by 2010. Peak incidence occurred between ages 40 and 50 years and maximum prevalence between ages 55 and 60 years. Women accounted for 72% of prevalent and 71% of incident cases. Scotland had the highest incidence and prevalence rates in the UK.RESULTSThe prevalence of MS recorded in GPRD increased by about 2.4% per year (95% CI 2.3% to 2.6%) reaching 285.8 per 100 000 in women (95% CI 278.7 to 293.1) and 113.1 per 100 000 in men (95% CI 108.6 to 117.7) by 2010. There was a consistent downward trend in incidence of MS reaching 11.52 per 100 000/year (95% CI 10.96 to 12.11) in women and 4.84 per 100 000/year (95% CI 4.54 to 5.16) in men by 2010. Peak incidence occurred between ages 40 and 50 years and maximum prevalence between ages 55 and 60 years. Women accounted for 72% of prevalent and 71% of incident cases. Scotland had the highest incidence and prevalence rates in the UK.We estimate that 126 669 people were living with MS in the UK in 2010 (203.4 per 100 000 population) and that 6003 new cases were diagnosed that year (9.64 per 100 000/year). There is an increasing population living longer with MS, which has important implications for resource allocation for MS in the UK.CONCLUSIONSWe estimate that 126 669 people were living with MS in the UK in 2010 (203.4 per 100 000 population) and that 6003 new cases were diagnosed that year (9.64 per 100 000/year). There is an increasing population living longer with MS, which has important implications for resource allocation for MS in the UK.
To estimate the incidence and prevalence of multiple sclerosis (MS) by age and describe secular trends and geographic variations within the UK over the 20-year period between 1990 and 2010 and hence to provide updated information on the impact of MS throughout the UK. A descriptive study. The study was carried out in the General Practice Research Database (GPRD), a primary care database representative of the UK population. Incidence and prevalence of MS per 100 000 population. Secular and geographical trends in incidence and prevalence of MS. The prevalence of MS recorded in GPRD increased by about 2.4% per year (95% CI 2.3% to 2.6%) reaching 285.8 per 100 000 in women (95% CI 278.7 to 293.1) and 113.1 per 100 000 in men (95% CI 108.6 to 117.7) by 2010. There was a consistent downward trend in incidence of MS reaching 11.52 per 100 000/year (95% CI 10.96 to 12.11) in women and 4.84 per 100 000/year (95% CI 4.54 to 5.16) in men by 2010. Peak incidence occurred between ages 40 and 50 years and maximum prevalence between ages 55 and 60 years. Women accounted for 72% of prevalent and 71% of incident cases. Scotland had the highest incidence and prevalence rates in the UK. We estimate that 126 669 people were living with MS in the UK in 2010 (203.4 per 100 000 population) and that 6003 new cases were diagnosed that year (9.64 per 100 000/year). There is an increasing population living longer with MS, which has important implications for resource allocation for MS in the UK.
ObjectivesTo estimate the incidence and prevalence of multiple sclerosis (MS) by age and describe secular trends and geographic variations within the UK over the 20-year period between 1990 and 2010 and hence to provide updated information on the impact of MS throughout the UK.DesignA descriptive study.SettingThe study was carried out in the General Practice Research Database (GPRD), a primary care database representative of the UK population.Main outcome measuresIncidence and prevalence of MS per 100000 population. Secular and geographical trends in incidence and prevalence of MS.ResultsThe prevalence of MS recorded in GPRD increased by about 2.4% per year (95% CI 2.3% to 2.6%) reaching 285.8 per 100000 in women (95% CI 278.7 to 293.1) and 113.1 per 100000 in men (95% CI 108.6 to 117.7) by 2010. There was a consistent downward trend in incidence of MS reaching 11.52 per 100000/year (95% CI 10.96 to 12.11) in women and 4.84 per 100000/year (95% CI 4.54 to 5.16) in men by 2010. Peak incidence occurred between ages 40 and 50years and maximum prevalence between ages 55 and 60years. Women accounted for 72% of prevalent and 71% of incident cases. Scotland had the highest incidence and prevalence rates in the UK.ConclusionsWe estimate that 126669 people were living with MS in the UK in 2010 (203.4 per 100000 population) and that 6003 new cases were diagnosed that year (9.64 per 100000/year). There is an increasing population living longer with MS, which has important implications for resource allocation for MS in the UK.
Objectives To estimate the incidence and prevalence of multiple sclerosis (MS) by age and describe secular trends and geographic variations within the UK over the 20-year period between 1990 and 2010 and hence to provide updated information on the impact of MS throughout the UK. Design A descriptive study. Setting The study was carried out in the General Practice Research Database (GPRD), a primary care database representative of the UK population. Main outcome measures Incidence and prevalence of MS per 100 000 population. Secular and geographical trends in incidence and prevalence of MS. Results The prevalence of MS recorded in GPRD increased by about 2.4% per year (95% CI 2.3% to 2.6%) reaching 285.8 per 100 000 in women (95% CI 278.7 to 293.1) and 113.1 per 100 000 in men (95% CI 108.6 to 117.7) by 2010. There was a consistent downward trend in incidence of MS reaching 11.52 per 100 000/year (95% CI 10.96 to 12.11) in women and 4.84 per 100 000/year (95% CI 4.54 to 5.16) in men by 2010. Peak incidence occurred between ages 40 and 50 years and maximum prevalence between ages 55 and 60 years. Women accounted for 72% of prevalent and 71% of incident cases. Scotland had the highest incidence and prevalence rates in the UK. Conclusions We estimate that 126 669 people were living with MS in the UK in 2010 (203.4 per 100 000 population) and that 6003 new cases were diagnosed that year (9.64 per 100 000/year). There is an increasing population living longer with MS, which has important implications for resource allocation for MS in the UK.
Author Bloomfield, G A
MacDonald, T M
Morant, S V
Mackenzie, I S
O'Riordan, J
AuthorAffiliation 3 Tayside Multiple Sclerosis Research Unit, Department of Neurology , Ninewells Hospital and Medical School , Dundee , UK
2 Multiple Sclerosis National Therapy Centres , Whitchurch , UK
1 Medicines Monitoring Unit (MEMO) , University of Dundee , Dundee , UK
AuthorAffiliation_xml – name: 3 Tayside Multiple Sclerosis Research Unit, Department of Neurology , Ninewells Hospital and Medical School , Dundee , UK
– name: 1 Medicines Monitoring Unit (MEMO) , University of Dundee , Dundee , UK
– name: 2 Multiple Sclerosis National Therapy Centres , Whitchurch , UK
Author_xml – sequence: 1
  givenname: I S
  surname: Mackenzie
  fullname: Mackenzie, I S
  email: i.s.mackenzie@dundee.ac.uk
  organization: Medicines Monitoring Unit (MEMO), University of Dundee, Dundee, UK
– sequence: 2
  givenname: S V
  surname: Morant
  fullname: Morant, S V
  email: i.s.mackenzie@dundee.ac.uk
  organization: Medicines Monitoring Unit (MEMO), University of Dundee, Dundee, UK
– sequence: 3
  givenname: G A
  surname: Bloomfield
  fullname: Bloomfield, G A
  email: i.s.mackenzie@dundee.ac.uk
  organization: Multiple Sclerosis National Therapy Centres, Whitchurch, UK
– sequence: 4
  givenname: T M
  surname: MacDonald
  fullname: MacDonald, T M
  email: i.s.mackenzie@dundee.ac.uk
  organization: Medicines Monitoring Unit (MEMO), University of Dundee, Dundee, UK
– sequence: 5
  givenname: J
  surname: O'Riordan
  fullname: O'Riordan, J
  email: i.s.mackenzie@dundee.ac.uk
  organization: Tayside Multiple Sclerosis Research Unit, Department of Neurology, Ninewells Hospital and Medical School, Dundee, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24052635$$D View this record in MEDLINE/PubMed
BookMark eNqFks9qFTEUxoNU7G1170oCbgQZzd-ZjAtBqtZiQREL7kImc8aby0xmTDIXuiv0EXxDn8SMty3ahc0iIZzf951zknOA9vzoAaHHlLyglJcvN95PBSOUF5xIIck9tKKiVAXn5NseWhHC2BIh--ggxg1ZlqofoH0miGQllyt0eeKta8FbwMa3eAqwNf2f69jhYe6Tm3rA0fYQxugidh6nNeCzj5jWNfl18TNnJ6-wwS1EG9yU3DbjaW7Pr9Fj8BBMjz8HY5PLxl8gggl2jd-aZBoT4SG635k-wqOr8xCdvX_39ehDcfrp-OTozWnRyJKnojONog3hxLQNcNkKlvuztmaUmwpsa7q2YlXeoKloRTuuKOuoUoIyS1hb8UP0euc7zc0ArQWfcmF6Cm4w4VyPxul_I96t9fdxq7lSquR1Nnh2ZRDGHzPEpAcXLfS98TDOUVMpaUkFE_JuVFSVzG1VNKNPb6GbcQ4-v4SmVe5B1KJWmXryd_E3VV9_ZQbIDrD5p2KA7gahRC_Topdp0cu06N20ZEl5S2JdMsmNS_uu_5_w-U7YDJu70_wGZFzSaA
CODEN JNNPAU
CitedBy_id crossref_primary_10_1111_bpa_12516
crossref_primary_10_1002_hbm_23531
crossref_primary_10_1016_j_msard_2017_01_002
crossref_primary_10_1016_j_exger_2023_112339
crossref_primary_10_1007_s11481_021_10004_9
crossref_primary_10_1007_s40258_016_0244_3
crossref_primary_10_1177_2055217320901727
crossref_primary_10_1016_j_neuroimage_2018_01_052
crossref_primary_10_1016_j_jneuroim_2018_02_012
crossref_primary_10_1007_s00415_017_8513_0
crossref_primary_10_1016_j_msard_2018_05_015
crossref_primary_10_1016_j_msard_2024_106190
crossref_primary_10_1016_j_msard_2017_11_001
crossref_primary_10_1016_j_msard_2019_07_028
crossref_primary_10_1016_j_jns_2021_117437
crossref_primary_10_1186_s12913_016_1562_8
crossref_primary_10_1302_0301_620X_100B7_BJJ_2017_1569_R1
crossref_primary_10_1016_j_brain_2024_100097
crossref_primary_10_1016_j_msard_2018_05_010
crossref_primary_10_1186_s12984_025_01612_0
crossref_primary_10_4103_SHB_SHB_23_18
crossref_primary_10_1016_j_msard_2019_01_011
crossref_primary_10_1016_j_msard_2024_106228
crossref_primary_10_1371_journal_pone_0155181
crossref_primary_10_1080_14737175_2020_1820325
crossref_primary_10_1371_journal_pone_0235562
crossref_primary_10_3389_fimmu_2019_02363
crossref_primary_10_1080_09638288_2020_1734105
crossref_primary_10_1002_acn3_51990
crossref_primary_10_3390_vaccines8010035
crossref_primary_10_1016_j_msard_2021_102963
crossref_primary_10_1038_s41409_019_0684_0
crossref_primary_10_1016_j_jenvrad_2015_12_003
crossref_primary_10_1177_1465312520949881
crossref_primary_10_1016_j_apmr_2016_12_007
crossref_primary_10_1111_ijcp_13300
crossref_primary_10_12688_wellcomeopenres_17731_1
crossref_primary_10_7224_1537_2073_2016_039
crossref_primary_10_1371_journal_pone_0152347
crossref_primary_10_1007_s10880_020_09711_x
crossref_primary_10_1177_1352458515576261
crossref_primary_10_1007_s11065_017_9357_1
crossref_primary_10_1371_journal_pone_0261983
crossref_primary_10_1186_s40945_018_0045_0
crossref_primary_10_1159_000505063
crossref_primary_10_1016_j_msard_2018_10_109
crossref_primary_10_7224_1537_2073_2017_022
crossref_primary_10_1016_j_msard_2023_104557
crossref_primary_10_1038_nri_2017_111
crossref_primary_10_1080_14712598_2017_1239706
crossref_primary_10_1080_09638288_2016_1181211
crossref_primary_10_1097_MD_0000000000015415
crossref_primary_10_1111_ene_13498
crossref_primary_10_1016_j_msard_2021_102979
crossref_primary_10_1136_bcr_2016_216618
crossref_primary_10_1016_j_msard_2019_04_032
crossref_primary_10_1177_1352458517708687
crossref_primary_10_1080_09638288_2022_2084774
crossref_primary_10_1177_1755738014551618
crossref_primary_10_1080_09602011_2018_1434081
crossref_primary_10_1007_s10654_025_01264_3
crossref_primary_10_1016_j_jbmt_2020_11_003
crossref_primary_10_1212_WNL_0000000000005612
crossref_primary_10_1007_s00415_019_09413_x
crossref_primary_10_1007_s10926_020_09952_5
crossref_primary_10_1186_s40814_015_0021_3
crossref_primary_10_1007_s00415_014_7370_3
crossref_primary_10_1111_ane_12631
crossref_primary_10_1007_s11065_018_9368_6
crossref_primary_10_1177_13524585241237708
crossref_primary_10_1212_WNL_0000000000002469
crossref_primary_10_1111_ene_13821
crossref_primary_10_1111_tog_12576
crossref_primary_10_1186_s13256_024_04985_3
crossref_primary_10_1016_j_nicl_2021_102814
crossref_primary_10_1007_s00415_015_7842_0
crossref_primary_10_1186_s40814_017_0168_1
crossref_primary_10_1155_2017_4960386
crossref_primary_10_1177_1352458514566416
crossref_primary_10_1186_1471_2377_14_128
crossref_primary_10_1136_bmjopen_2015_008274
crossref_primary_10_2196_22122
crossref_primary_10_1159_000481990
crossref_primary_10_1016_j_media_2024_103436
crossref_primary_10_1016_j_msard_2020_102444
crossref_primary_10_1016_S1474_4422_18_30498_8
crossref_primary_10_1016_j_nrleng_2020_07_022
crossref_primary_10_1080_00243639_2017_1360065
crossref_primary_10_1007_s00417_020_04669_w
crossref_primary_10_1136_bmj_2020_061514
crossref_primary_10_12688_wellcomeopenres_16349_1
crossref_primary_10_1007_s00415_020_09969_z
crossref_primary_10_7224_1537_2073_2015_038
crossref_primary_10_1016_j_msard_2022_103840
crossref_primary_10_36290_uro_2017_027
crossref_primary_10_1111_jon_12474
crossref_primary_10_17795_ajnpp_38613
crossref_primary_10_1111_jocn_13593
crossref_primary_10_3390_molecules28010002
crossref_primary_10_1177_1352458518783345
crossref_primary_10_12968_bjon_2018_27_3_132
crossref_primary_10_1111_ane_12615
crossref_primary_10_3389_fneur_2019_00953
crossref_primary_10_1212_CON_0000000000001157
crossref_primary_10_1111_imm_12922
crossref_primary_10_7224_1537_2073_2019_058
crossref_primary_10_1002_acn3_323
crossref_primary_10_1111_cen3_12432
crossref_primary_10_3389_fresc_2022_966133
crossref_primary_10_1111_1460_6984_12235
crossref_primary_10_1038_s41467_024_44917_9
crossref_primary_10_1080_09638288_2016_1180547
crossref_primary_10_1136_jim_2020_001609
crossref_primary_10_1212_WNL_0000000000207981
crossref_primary_10_1016_j_apmr_2015_07_022
crossref_primary_10_1002_brb3_276
crossref_primary_10_1186_s13023_016_0457_4
crossref_primary_10_1080_01616412_2021_1952511
crossref_primary_10_3389_fimmu_2025_1570565
crossref_primary_10_1016_j_msard_2017_02_010
crossref_primary_10_3233_BMR_191518
crossref_primary_10_1016_j_apjtb_2017_02_001
crossref_primary_10_1016_j_jval_2019_08_009
crossref_primary_10_3389_fendo_2019_00265
crossref_primary_10_1007_s12020_015_0562_5
crossref_primary_10_1080_09602011_2017_1309323
crossref_primary_10_1177_1352458516638746
crossref_primary_10_1007_s00415_017_8527_7
crossref_primary_10_1177_1044207319893621
crossref_primary_10_1002_ana_25835
crossref_primary_10_1016_j_amjmed_2023_07_004
crossref_primary_10_3389_fimmu_2024_1345625
crossref_primary_10_1016_j_jval_2018_03_019
crossref_primary_10_1177_1352458517732841
crossref_primary_10_12688_f1000research_9522_1
crossref_primary_10_1212_NXI_0000000000000992
crossref_primary_10_1371_journal_pone_0158982
crossref_primary_10_3390_brainsci10060345
crossref_primary_10_1016_j_exger_2021_111347
crossref_primary_10_2217_nmt_2018_0043
crossref_primary_10_1016_j_hkpj_2016_03_002
crossref_primary_10_1007_s00415_023_11971_0
crossref_primary_10_1186_s13063_017_1890_y
crossref_primary_10_1038_s41598_022_26409_2
crossref_primary_10_3390_bs9070070
crossref_primary_10_1016_j_msard_2023_104757
crossref_primary_10_12968_bjon_2022_31_Sup3_S1
crossref_primary_10_1016_j_biopha_2021_112610
crossref_primary_10_1016_j_conctc_2024_101279
crossref_primary_10_1136_jnnp_2013_307187
crossref_primary_10_7224_1537_2073_2014_011
crossref_primary_10_3389_fneur_2020_01012
crossref_primary_10_1016_j_msard_2020_102657
crossref_primary_10_1016_j_msard_2020_101963
crossref_primary_10_1177_1545968320907074
crossref_primary_10_1177_20552173211001571
crossref_primary_10_1111_hsc_12369
crossref_primary_10_1259_bjr_20180926
crossref_primary_10_1212_WNL_0000000000002543
crossref_primary_10_2217_nmt_14_45
crossref_primary_10_1016_j_exger_2020_111025
crossref_primary_10_1016_j_jsams_2023_10_009
crossref_primary_10_1080_08870446_2016_1268691
crossref_primary_10_1016_j_lanepe_2024_100977
crossref_primary_10_1016_j_ucl_2024_06_009
crossref_primary_10_1016_j_msard_2024_105512
crossref_primary_10_1093_occmed_kqx083
crossref_primary_10_1016_j_msard_2022_104065
crossref_primary_10_1038_s41598_021_86347_3
crossref_primary_10_1016_j_msard_2022_103932
crossref_primary_10_1136_bcr_2017_220384
crossref_primary_10_1371_journal_pone_0236432
crossref_primary_10_1016_j_msard_2022_103534
crossref_primary_10_7224_1537_2073_2021_053
crossref_primary_10_1007_s10654_025_01243_8
crossref_primary_10_1136_bmjopen_2018_026421
crossref_primary_10_1016_j_msard_2022_103928
crossref_primary_10_3389_fmed_2018_00220
crossref_primary_10_1136_bmjopen_2021_058506
crossref_primary_10_1016_j_apjtb_2016_03_009
crossref_primary_10_1097_WAD_0000000000000152
crossref_primary_10_1007_s40273_016_0421_0
crossref_primary_10_1016_j_jval_2015_05_006
crossref_primary_10_1080_14737175_2024_2304116
Cites_doi 10.1136/bmj.327.7410.316
10.1016/S0140-6736(97)04248-7
10.1136/jnnp.2010.232108
10.1111/j.1600-0447.1960.tb08674.x
10.1002/ana.22678
10.1136/jnnp.54.2.104
10.1136/jnnp.2011.240432
10.1212/01.wnl.0000316802.35974.34
10.1093/oxfordjournals.aje.a009746
10.1073/pnas.93.15.7861
10.1136/bmj.38301.686030.63
10.2165/00019053-200826100-00005
10.1136/jnnp-2012-303934
10.1093/brain/118.1.253
10.1212/WNL.26.6_Part_2.14
10.1111/j.1468-1331.2010.03003.x
10.1093/brain/79.4.635
10.1136/jnnp.49.10.1115
10.1136/jnnp.2010.220988
10.1016/S1474-4422(10)70064-8
10.1136/bmj.3.5777.725
10.1007/s00415-007-0602-z
10.1371/journal.pone.0048078
10.1007/s004150050509
10.1177/1352458512446169
10.1007/s10198-006-0380-z
ContentType Journal Article
Copyright Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Copyright: 2014 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2014
Copyright_xml – notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
– notice: Copyright: 2014 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
– notice: Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2014
DBID 9YT
ACMMV
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7X7
7XB
88E
88G
88I
8AF
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
BTHHO
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB0
M0S
M1P
M2M
M2P
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
7TK
5PM
DOI 10.1136/jnnp-2013-305450
DatabaseName BMJ Open Access Journals (Free internet resource, activated by CARLI)
BMJ Journals:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Science Database (Alumni Edition)
STEM Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
BMJ Journals
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database
ProQuest - Psychology Database
Science Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
Neurosciences Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
BMJ Journals
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList MEDLINE - Academic
MEDLINE
Neurosciences Abstracts

ProQuest One Psychology
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7RV
  name: Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Geography
EISSN 1468-330X
EndPage 84
ExternalDocumentID PMC3888639
4023923401
24052635
10_1136_jnnp_2013_305450
jnnp
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United Kingdom--UK
England
Wales
GeographicLocations_xml – name: Wales
– name: England
– name: United Kingdom--UK
GroupedDBID ---
.55
.GJ
.VT
0R~
18M
29L
2WC
354
39C
3O-
4.4
40O
41~
53G
5GY
5RE
5VS
7RV
7X7
7~S
88E
88I
8AF
8FI
8FJ
8R4
8R5
9YT
AAHLL
AAKAS
AAOJX
AAUVZ
AAWJN
AAWTL
ABAAH
ABIVO
ABJNI
ABKDF
ABMQD
ABOCM
ABUWG
ABVAJ
ACGFO
ACGFS
ACGOD
ACGTL
ACHTP
ACMFJ
ACMMV
ACOAB
ACOFX
ACQSR
ACTZY
ADBBV
ADCEG
ADFRT
ADUGQ
ADZCM
AEKJL
AENEX
AFKRA
AFWFF
AGQPQ
AHMBA
AHNKE
AHQMW
AI.
AJYBZ
AKKEP
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZFZN
AZQEC
BAWUL
BENPR
BLJBA
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C45
CAG
CCPQU
COF
CS3
CXRWF
DIK
DU5
DWQXO
E3Z
EBS
EJD
EX3
F5P
FEDTE
FYUFA
GNUQQ
GX1
H13
HAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IAO
IEA
IHR
INH
INR
IOF
IPO
IPY
ITC
J5H
KQ8
L7B
M1P
M2M
M2P
N9A
NAPCQ
NTWIH
NXWIF
O9-
OK1
OMB
OMG
OVD
P2P
PCD
PHGZT
PQQKQ
PROAC
PSQYO
PSYQQ
Q2X
R53
RHI
RMJ
RPM
RV8
SJN
TEORI
TR2
UKHRP
UPT
UYXKK
V24
VH1
VM9
VVN
W8F
WH7
WOW
X7M
YFH
YQT
YQY
ZGI
AAYXX
ACQHZ
AERUA
AFFHD
CITATION
PHGZM
PJZUB
PPXIY
ADGHP
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
7TK
PUEGO
5PM
ID FETCH-LOGICAL-b563t-fab81b030adbe35d42002cc9213a7ecdafd727fd7eb7171f3812f188412c02d73
IEDL.DBID 7RV
ISICitedReferencesCount 148
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000335439000016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0022-3050
1468-330X
IngestDate Tue Nov 04 01:58:58 EST 2025
Fri Sep 05 08:31:54 EDT 2025
Sun Nov 09 13:34:09 EST 2025
Tue Oct 07 07:23:03 EDT 2025
Mon Jul 21 05:48:26 EDT 2025
Tue Nov 18 22:42:32 EST 2025
Sat Nov 29 02:36:57 EST 2025
Thu Apr 24 23:07:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Multiple Sclerosis
Epidemiology
Language English
License This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b563t-fab81b030adbe35d42002cc9213a7ecdafd727fd7eb7171f3812f188412c02d73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC3888639
PMID 24052635
PQID 1781249498
PQPubID 2041879
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3888639
proquest_miscellaneous_1551614245
proquest_miscellaneous_1477556371
proquest_journals_1781249498
pubmed_primary_24052635
crossref_primary_10_1136_jnnp_2013_305450
crossref_citationtrail_10_1136_jnnp_2013_305450
bmj_primary_10_1136_jnnp_2013_305450
PublicationCentury 2000
PublicationDate 2014-01-01
PublicationDateYYYYMMDD 2014-01-01
PublicationDate_xml – month: 01
  year: 2014
  text: 2014-01-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
– name: BMA House, Tavistock Square, London, WC1H 9JR
PublicationSeriesTitle Research paper
PublicationTitle Journal of neurology, neurosurgery and psychiatry
PublicationTitleAlternate J Neurol Neurosurg Psychiatry
PublicationYear 2014
Publisher BMJ Publishing Group LTD
BMJ Publishing Group
Publisher_xml – name: BMJ Publishing Group LTD
– name: BMJ Publishing Group
References Trojano, Lucchese, Graziano 2012; 7
Poskanzer, Walker, Yonkondy 1976; 26
Lonergan, Kinsella, Fitzpatrick 2011; 82
Willer, Dyment, Sadovnick 2005; 330
Herrett, Thomas, Schoonen 2010; 69
Cantorna, Hayes, DeLuca 1996; 93
Sutherland 1956; 76
Forbes, Wilson, Swingler 1999; 246
Ramagopalan, Dyment, Cader 2011; 70
Runmarker, Andersen 1995; 118
Ramagopalan, Hoang, Seagroatt 2011; 82
Swingler, Compston 1986; 49
Alonso, Jick, Olek 2007; 254
Alonso, Hernán 2008; 71
Dean, Kurtzke 1971; 3
Van der Mei, Ponsonby, Dwyer 2003; 327
Koch-Henriksen, Sorensen 2010; 9
Handel, Handunnethi, Giovannnoni 2010; 17
Kobelt, Berg, Lindgren 2006; 7
Williams, Jones, McKeran 1991; 54
Forbes, Swingler 1999; 149
Dobson, Giovannoni, Ramagopalan 2013; 84
Simpson, Blizzard, Otahal 2011; 82
McCrone, Heslin, Knapp 2008; 26
Boström, Stawiarz, Landtblom 2013; 19
Acheson, Bachrach, Wright 1960; 35
Walley, Mantgani 1997; 350
Ramagopalan (key-10.1136/jnnp-2013-305450-31) 2011; 70
Lonergan (key-10.1136/jnnp-2013-305450-25) 2011; 82
Forbes (key-10.1136/jnnp-2013-305450-26) 1999; 246
key-10.1136/jnnp-2013-305450-9
Poskanzer (key-10.1136/jnnp-2013-305450-22) 1976; 26
key-10.1136/jnnp-2013-305450-7
key-10.1136/jnnp-2013-305450-10
key-10.1136/jnnp-2013-305450-13
Williams (key-10.1136/jnnp-2013-305450-4) 1991; 54
Alonso (key-10.1136/jnnp-2013-305450-14) 2008; 71
Van der Mei (key-10.1136/jnnp-2013-305450-24) 2003; 327
Herrett (key-10.1136/jnnp-2013-305450-12) 2010; 69
Dean (key-10.1136/jnnp-2013-305450-23) 1971; 3
Cantorna (key-10.1136/jnnp-2013-305450-30) 1996; 93
Runmarker (key-10.1136/jnnp-2013-305450-11) 1995; 118
Swingler (key-10.1136/jnnp-2013-305450-3) 1986; 49
Sutherland (key-10.1136/jnnp-2013-305450-20) 1956; 76
McCrone (key-10.1136/jnnp-2013-305450-1) 2008; 26
Alonso (key-10.1136/jnnp-2013-305450-6) 2007; 254
Forbes (key-10.1136/jnnp-2013-305450-5) 1999; 149
Boström (key-10.1136/jnnp-2013-305450-17) 2013; 19
Dobson (key-10.1136/jnnp-2013-305450-29) 2013; 84
Kobelt (key-10.1136/jnnp-2013-305450-2) 2006; 7
Koch-Henriksen (key-10.1136/jnnp-2013-305450-15) 2010; 9
Simpson (key-10.1136/jnnp-2013-305450-18) 2011; 82
Ramagopalan (key-10.1136/jnnp-2013-305450-19) 2011; 82
Walley (key-10.1136/jnnp-2013-305450-8) 1997; 350
Willer (key-10.1136/jnnp-2013-305450-28) 2005; 330
Handel (key-10.1136/jnnp-2013-305450-27) 2010; 17
Trojano (key-10.1136/jnnp-2013-305450-16) 2012; 7
Acheson (key-10.1136/jnnp-2013-305450-21) 1960; 35
2019834 - J Neurol Neurosurg Psychiatry. 1991 Feb;54(2):104-9
17310341 - Eur J Health Econ. 2006 Sep;7 Suppl 2:S96-104
20398859 - Lancet Neurol. 2010 May;9(5):520-32
23133550 - PLoS One. 2012;7(10):e48078
3783172 - J Neurol Neurosurg Psychiatry. 1986 Oct;49(10):1115-24
18606967 - Neurology. 2008 Jul 8;71(2):129-35
7895009 - Brain. 1995 Feb;118 ( Pt 1):253-61
15585537 - BMJ. 2005 Jan 15;330(7483):120
18793032 - Pharmacoeconomics. 2008;26(10):847-60
12907484 - BMJ. 2003 Aug 9;327(7410):316
17896096 - J Neurol. 2007 Dec;254(12):1736-41
20078607 - Br J Clin Pharmacol. 2010 Jan;69(1):4-14
21212107 - J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):682-7
944886 - Neurology. 1976 Jun;26(6 PT 2):14-7
21478203 - J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1132-41
22711712 - Mult Scler. 2013 Jan;19(1):46-52
10631635 - J Neurol. 1999 Nov;246(11):1033-40
13396068 - Brain. 1956 Dec;79(4):635-54
8755567 - Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7861-4
22190362 - Ann Neurol. 2011 Dec;70(6):881-6
10213569 - Lancet. 1997 Oct 11;350(9084):1097-9
5097967 - Br Med J. 1971 Sep 25;3(5777):725-9
20345929 - Eur J Neurol. 2010 Sep;17(9):1210-4
10355377 - Am J Epidemiol. 1999 Jun 1;149(11):1016-24
21248317 - J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):317-22
13681205 - Acta Psychiatr Scand Suppl. 1960;35(147):132-47
23152637 - J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):427-32
References_xml – volume: 26
  start-page: 14
  year: 1976
  article-title: Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands
  publication-title: Neurology
– volume: 93
  start-page: 7861
  year: 1996
  article-title: 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis
  publication-title: Proc Natl Acad Sci USA
– volume: 17
  start-page: 1210
  year: 2010
  article-title: Genetic and environmental factors and the distribution of multiple sclerosis in Europe
  publication-title: Eur J Neurol
– volume: 246
  start-page: 1033
  year: 1999
  article-title: The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist
  publication-title: J Neurol
– volume: 70
  start-page: 881
  year: 2011
  article-title: Rare variants in the CYP27B1 gene associated with multiple sclerosis
  publication-title: Ann Neurol
– volume: 327
  start-page: 316
  year: 2003
  article-title: Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study
  publication-title: BMJ
– volume: 9
  start-page: 520
  year: 2010
  article-title: The changing demographic pattern of multiple sclerosis epidemiology
  publication-title: Lancet Neurol
– volume: 54
  start-page: 104
  year: 1991
  article-title: Mortality rates from multiple sclerosis: geographical and temporal variations revisited
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 254
  start-page: 1736
  year: 2007
  article-title: Incidence of multiple sclerosis in the United Kingdom: findings from a population-based cohort
  publication-title: J Neurol
– volume: 350
  start-page: 1097
  year: 1997
  article-title: The UK General Practice Research Database
  publication-title: Lancet
– volume: 76
  start-page: 635
  year: 1956
  article-title: Observations on the prevalence of multiple sclerosis in Northern Scotland
  publication-title: Brain
– volume: 35
  start-page: 132
  year: 1960
  article-title: Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables
  publication-title: Acta Psychiat (Scand)
– volume: 82
  start-page: 1132
  year: 2011
  article-title: Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 3
  start-page: 725
  year: 1971
  article-title: On the risk of multiple sclerosis according to age at immigration to South Africa
  publication-title: BMJ
– volume: 26
  start-page: 847
  year: 2008
  article-title: Multiple sclerosis in the UK Service use, costs, quality of life and disability
  publication-title: Pharmacoeconomics
– volume: 82
  start-page: 682
  year: 2011
  article-title: Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: a descriptive study
  publication-title: J Neurol Neurosurg Psychiatry.
– volume: 19
  start-page: 46
  year: 2013
  article-title: Sex ratio of multiple sclerosis in the National Swedish MS register
  publication-title: Multiple Sclerosis
– volume: 71
  start-page: 129
  year: 2008
  article-title: Temporal trends in the incidence of multiple sclerosis: a systematic review
  publication-title: Neurology
– volume: 49
  start-page: 1115
  year: 1986
  article-title: The distribution of multiple sclerosis in the United Kingdom
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 149
  start-page: 1016
  year: 1999
  article-title: Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology
  publication-title: Am J Epidemiol
– volume: 69
  start-page: 4
  year: 2010
  article-title: Validation and validity of diagnoses in the General Practice Research Database: a systematic review
  publication-title: BJCP
– volume: 118
  start-page: 253
  year: 1995
  article-title: Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis
  publication-title: Brain
– volume: 84
  start-page: 427
  year: 2013
  article-title: The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude
  publication-title: J Neurol Neurosurg Psychiatry
– volume: 330
  start-page: 120
  year: 2005
  article-title: Timing of birth and risk of multiple sclerosis: population based study
  publication-title: BMJ
– volume: 7
  start-page: S96
  issue: (Suppl 2)
  year: 2006
  article-title: Costs and quality of life of multiple sclerosis in the United Kingdom
  publication-title: Eur J Health Econ
– volume: 7
  start-page: 1
  year: 2012
  article-title: Geographical variations in sex ratio trends over time in multiple sclerosis
  publication-title: PLOS one
– volume: 82
  start-page: 317
  year: 2011
  article-title: Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype
  publication-title: J Neurol Neurosurg Psychiatry.
– volume: 327
  start-page: 316
  year: 2003
  ident: key-10.1136/jnnp-2013-305450-24
  article-title: Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study
  publication-title: BMJ
  doi: 10.1136/bmj.327.7410.316
– ident: key-10.1136/jnnp-2013-305450-13
– volume: 350
  start-page: 1097
  year: 1997
  ident: key-10.1136/jnnp-2013-305450-8
  article-title: The UK General Practice Research Database
  publication-title: Lancet
  doi: 10.1016/S0140-6736(97)04248-7
– volume: 82
  start-page: 682
  year: 2011
  ident: key-10.1136/jnnp-2013-305450-19
  article-title: Geography of hospital admissions for multiple sclerosis in England and comparison with the geography of hospital admissions for infectious mononucleosis: a descriptive study
  publication-title: J Neurol Neurosurg Psychiatry.
  doi: 10.1136/jnnp.2010.232108
– volume: 35
  start-page: 132
  year: 1960
  ident: key-10.1136/jnnp-2013-305450-21
  article-title: Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables
  publication-title: Acta Psychiat (Scand)
  doi: 10.1111/j.1600-0447.1960.tb08674.x
– volume: 70
  start-page: 881
  year: 2011
  ident: key-10.1136/jnnp-2013-305450-31
  article-title: Rare variants in the CYP27B1 gene associated with multiple sclerosis
  publication-title: Ann Neurol
  doi: 10.1002/ana.22678
– volume: 54
  start-page: 104
  year: 1991
  ident: key-10.1136/jnnp-2013-305450-4
  article-title: Mortality rates from multiple sclerosis: geographical and temporal variations revisited
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.54.2.104
– volume: 82
  start-page: 1132
  year: 2011
  ident: key-10.1136/jnnp-2013-305450-18
  article-title: Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.2011.240432
– volume: 71
  start-page: 129
  year: 2008
  ident: key-10.1136/jnnp-2013-305450-14
  article-title: Temporal trends in the incidence of multiple sclerosis: a systematic review
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000316802.35974.34
– volume: 149
  start-page: 1016
  year: 1999
  ident: key-10.1136/jnnp-2013-305450-5
  article-title: Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology
  publication-title: Am J Epidemiol
  doi: 10.1093/oxfordjournals.aje.a009746
– volume: 93
  start-page: 7861
  year: 1996
  ident: key-10.1136/jnnp-2013-305450-30
  article-title: 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.93.15.7861
– volume: 330
  start-page: 120
  year: 2005
  ident: key-10.1136/jnnp-2013-305450-28
  article-title: Timing of birth and risk of multiple sclerosis: population based study
  publication-title: BMJ
  doi: 10.1136/bmj.38301.686030.63
– volume: 26
  start-page: 847
  year: 2008
  ident: key-10.1136/jnnp-2013-305450-1
  article-title: Multiple sclerosis in the UK Service use, costs, quality of life and disability
  publication-title: Pharmacoeconomics
  doi: 10.2165/00019053-200826100-00005
– volume: 84
  start-page: 427
  year: 2013
  ident: key-10.1136/jnnp-2013-305450-29
  article-title: The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp-2012-303934
– volume: 118
  start-page: 253
  year: 1995
  ident: key-10.1136/jnnp-2013-305450-11
  article-title: Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis
  publication-title: Brain
  doi: 10.1093/brain/118.1.253
– volume: 26
  start-page: 14
  year: 1976
  ident: key-10.1136/jnnp-2013-305450-22
  article-title: Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands
  publication-title: Neurology
  doi: 10.1212/WNL.26.6_Part_2.14
– volume: 17
  start-page: 1210
  year: 2010
  ident: key-10.1136/jnnp-2013-305450-27
  article-title: Genetic and environmental factors and the distribution of multiple sclerosis in Europe
  publication-title: Eur J Neurol
  doi: 10.1111/j.1468-1331.2010.03003.x
– volume: 76
  start-page: 635
  year: 1956
  ident: key-10.1136/jnnp-2013-305450-20
  article-title: Observations on the prevalence of multiple sclerosis in Northern Scotland
  publication-title: Brain
  doi: 10.1093/brain/79.4.635
– volume: 49
  start-page: 1115
  year: 1986
  ident: key-10.1136/jnnp-2013-305450-3
  article-title: The distribution of multiple sclerosis in the United Kingdom
  publication-title: J Neurol Neurosurg Psychiatry
  doi: 10.1136/jnnp.49.10.1115
– ident: key-10.1136/jnnp-2013-305450-7
– volume: 82
  start-page: 317
  year: 2011
  ident: key-10.1136/jnnp-2013-305450-25
  article-title: Multiple sclerosis prevalence in Ireland: relationship to vitamin D status and HLA genotype
  publication-title: J Neurol Neurosurg Psychiatry.
  doi: 10.1136/jnnp.2010.220988
– ident: key-10.1136/jnnp-2013-305450-9
– volume: 9
  start-page: 520
  year: 2010
  ident: key-10.1136/jnnp-2013-305450-15
  article-title: The changing demographic pattern of multiple sclerosis epidemiology
  publication-title: Lancet Neurol
  doi: 10.1016/S1474-4422(10)70064-8
– volume: 3
  start-page: 725
  year: 1971
  ident: key-10.1136/jnnp-2013-305450-23
  article-title: On the risk of multiple sclerosis according to age at immigration to South Africa
  publication-title: BMJ
  doi: 10.1136/bmj.3.5777.725
– volume: 69
  start-page: 4
  year: 2010
  ident: key-10.1136/jnnp-2013-305450-12
  article-title: Validation and validity of diagnoses in the General Practice Research Database: a systematic review
  publication-title: BJCP
– volume: 254
  start-page: 1736
  year: 2007
  ident: key-10.1136/jnnp-2013-305450-6
  article-title: Incidence of multiple sclerosis in the United Kingdom: findings from a population-based cohort
  publication-title: J Neurol
  doi: 10.1007/s00415-007-0602-z
– volume: 7
  start-page: 1
  year: 2012
  ident: key-10.1136/jnnp-2013-305450-16
  article-title: Geographical variations in sex ratio trends over time in multiple sclerosis
  publication-title: PLOS one
  doi: 10.1371/journal.pone.0048078
– ident: key-10.1136/jnnp-2013-305450-10
– volume: 246
  start-page: 1033
  year: 1999
  ident: key-10.1136/jnnp-2013-305450-26
  article-title: The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist
  publication-title: J Neurol
  doi: 10.1007/s004150050509
– volume: 19
  start-page: 46
  year: 2013
  ident: key-10.1136/jnnp-2013-305450-17
  article-title: Sex ratio of multiple sclerosis in the National Swedish MS register
  publication-title: Multiple Sclerosis
  doi: 10.1177/1352458512446169
– volume: 7
  start-page: S96
  issue: (Suppl 2)
  year: 2006
  ident: key-10.1136/jnnp-2013-305450-2
  article-title: Costs and quality of life of multiple sclerosis in the United Kingdom
  publication-title: Eur J Health Econ
  doi: 10.1007/s10198-006-0380-z
– reference: 15585537 - BMJ. 2005 Jan 15;330(7483):120
– reference: 22711712 - Mult Scler. 2013 Jan;19(1):46-52
– reference: 17310341 - Eur J Health Econ. 2006 Sep;7 Suppl 2:S96-104
– reference: 944886 - Neurology. 1976 Jun;26(6 PT 2):14-7
– reference: 20398859 - Lancet Neurol. 2010 May;9(5):520-32
– reference: 22190362 - Ann Neurol. 2011 Dec;70(6):881-6
– reference: 7895009 - Brain. 1995 Feb;118 ( Pt 1):253-61
– reference: 21248317 - J Neurol Neurosurg Psychiatry. 2011 Mar;82(3):317-22
– reference: 18793032 - Pharmacoeconomics. 2008;26(10):847-60
– reference: 18606967 - Neurology. 2008 Jul 8;71(2):129-35
– reference: 10213569 - Lancet. 1997 Oct 11;350(9084):1097-9
– reference: 10355377 - Am J Epidemiol. 1999 Jun 1;149(11):1016-24
– reference: 10631635 - J Neurol. 1999 Nov;246(11):1033-40
– reference: 23152637 - J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):427-32
– reference: 21478203 - J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1132-41
– reference: 21212107 - J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):682-7
– reference: 2019834 - J Neurol Neurosurg Psychiatry. 1991 Feb;54(2):104-9
– reference: 8755567 - Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7861-4
– reference: 23133550 - PLoS One. 2012;7(10):e48078
– reference: 5097967 - Br Med J. 1971 Sep 25;3(5777):725-9
– reference: 13681205 - Acta Psychiatr Scand Suppl. 1960;35(147):132-47
– reference: 17896096 - J Neurol. 2007 Dec;254(12):1736-41
– reference: 13396068 - Brain. 1956 Dec;79(4):635-54
– reference: 12907484 - BMJ. 2003 Aug 9;327(7410):316
– reference: 20345929 - Eur J Neurol. 2010 Sep;17(9):1210-4
– reference: 20078607 - Br J Clin Pharmacol. 2010 Jan;69(1):4-14
– reference: 3783172 - J Neurol Neurosurg Psychiatry. 1986 Oct;49(10):1115-24
SSID ssj0000089
Score 2.5466564
Snippet Objectives To estimate the incidence and prevalence of multiple sclerosis (MS) by age and describe secular trends and geographic variations within the UK over...
To estimate the incidence and prevalence of multiple sclerosis (MS) by age and describe secular trends and geographic variations within the UK over the 20-year...
ObjectivesTo estimate the incidence and prevalence of multiple sclerosis (MS) by age and describe secular trends and geographic variations within the UK over...
SourceID pubmedcentral
proquest
pubmed
crossref
bmj
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 76
SubjectTerms Adult
Age
Age Factors
Aged
Aged, 80 and over
Databases, Factual
Disease
Female
Follow-Up Studies
General Practice - statistics & numerical data
Geography
Hospitalization - statistics & numerical data
Hospitals
Humans
Incidence
Longitudinal Studies
Male
Middle Aged
Mortality
Multiple Sclerosis
Multiple Sclerosis - epidemiology
Patients
Population
Practice research
Prevalence
Regression analysis
Sex Factors
Treatment Outcome
United Kingdom - epidemiology
Womens health
Young Adult
Title Incidence and prevalence of multiple sclerosis in the UK 1990–2010: a descriptive study in the General Practice Research Database
URI https://jnnp.bmj.com/content/85/1/76.full
https://www.ncbi.nlm.nih.gov/pubmed/24052635
https://www.proquest.com/docview/1781249498
https://www.proquest.com/docview/1477556371
https://www.proquest.com/docview/1551614245
https://pubmed.ncbi.nlm.nih.gov/PMC3888639
Volume 85
WOSCitedRecordID wos000335439000016&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection (ProQuest)
  customDbUrl:
  eissn: 1468-330X
  dateEnd: 20250607
  omitProxy: false
  ssIdentifier: ssj0000089
  issn: 0022-3050
  databaseCode: 7X7
  dateStart: 19440701
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1468-330X
  dateEnd: 20250607
  omitProxy: false
  ssIdentifier: ssj0000089
  issn: 0022-3050
  databaseCode: 7RV
  dateStart: 19440701
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1468-330X
  dateEnd: 20250607
  omitProxy: false
  ssIdentifier: ssj0000089
  issn: 0022-3050
  databaseCode: BENPR
  dateStart: 19440701
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Psychology Database (ProQuest)
  customDbUrl:
  eissn: 1468-330X
  dateEnd: 20250607
  omitProxy: false
  ssIdentifier: ssj0000089
  issn: 0022-3050
  databaseCode: M2M
  dateStart: 19440701
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/psychology
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database (ProQuest)
  customDbUrl:
  eissn: 1468-330X
  dateEnd: 20250607
  omitProxy: false
  ssIdentifier: ssj0000089
  issn: 0022-3050
  databaseCode: M2P
  dateStart: 19440701
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BixAX3o9AqYzUC4do48RZO1wQj1ZIaFeriqK9RY4f6laQXTbb3vnnzCRO6IK0HLhYsjyOYs14ZuwZfwNwpATBnSYixmOXj4XVHvecdbFBZSm0EpkVvi02IadTNZ8Xs3Dh1oS0yl4ntoraLg3dkY-4JFNUiEK9Xf2IqWoURVdDCY2bsM_JdqM8y9Ov19xfVQxo4Ume9GHKbDy6qOsVSgjPaEC0r-6r7xfbxukvj_PPxMlrlujk3v-u4T7cDT4oe9cJzQO44eqHcHsSouyP4Ccqja7WKNO1Zas1QYK33aVnfQYia3AurmLRsEXN0I1kZ58ZR4bQepM3TDPrgkq6QmJCse0JA9Q1m4UXWqxP_2Mf9UaTXX0MZyfHXz58ikOphrjKx9km9rpC_xcVhraVy3IrKPfDmCLlmZbOoAhYdJSwcRWeH7lHPyH1XCnBU5OkVmZPYK9e1u4ZMKO1UmZcce8KIXOtfGpz_DJaCFlxayI4Qk6Vqw6Mo2wPMdm4JIaWxNCyY2gEo56VpQlw51R149uOGa-HGf_--kHP4TJs-qb8zd4IXg3DuF0pBqNrt7xEGiElYbJJvoOGgpf0AjGP4GkncMMPoQOWE35QBHJLFAcCggvfHqkX5y1seKaUQn_0-e5ffwF3cJ2iu2U6gL3N-tK9hFvmarNo1oft_qJ2LttWHcL---Pp7BR7k3TStrNfGowx6Q
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoALz9IGChipHDhEGyfO2kFCCFGqVtuuemilvQXHdsRWNLvdbIt67B_iNzKTF12QllMPXCJFHluO83lmbI-_AdhSguhOA-Hjsiv3hdU5zjnrfIPKUmglIivyKtmEHA7VaJQcrsDP9i4MhVW2OrFS1HZiaI-8xyWZokQk6uP0zKesUXS62qbQqGExcJc_cMlWftjbxv_7Ngx3vhx93vWbrAJ-FvejuZ_rDF01xLa2mYtiKyhMwZgk5JGWzmBvLdp0fLgMlzo8R5MW5lwpwUMThFZG2O4tuI16XFIImRzJa-62Sjp28iAO2mPRqN87KYopIpJHVCCqW_7Z6cmiMfzLw_0zUPOa5dt5-L-N2SN40PjY7FM9KR7DiiuewN2DJorgKVyhUqxzqTJdWDadEeV59TrJWRthyUqsi6M2Ltm4YOgms-MB4wg4Gt_gPdPMukblXqAwsfS2gg2VNztsbqCxNryRbeu5Jr9hDY5vZACewWoxKdwGMKO1Uqaf8dwlQsZa5aGNsWW0gDLj1niwhchIpzXZSFot0qJ-SgBKCUBpDSAPei10UtPQuVNWke9Larzravy79c0WUWmj1Mr0N5w8eNMVozqiMyZduMk5yggpiXNO8iUydDhLNyxjD9ZrgHcdQgczJn4kD-QC9DsBokNfLCnG3ypa9Egphf728-Vdfw33do8O9tP9veHgBdzHbxb1jtomrM5n5-4l3DEX83E5e1XNbQZfb3pi_AJsk4nd
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VgiouvB-GAotUDhyseO11do2EECJEVKFRDlTqzaz3IVK1TojTIo78LX4dM36EBqRw6oGLJWtnV5vNN4_1zn4DsKcE0Z1GIsRtlw-F1R51zrrQoLEUWonECl8Xm5DjsTo6yiZb8LO7C0NplZ1NrA21nRn6Rt7jklxRJjLV821axGQwfDP_GlIFKTpp7cppNBAZue_fcPtWvd4f4H_9Io6H7z-9-xC2FQbCIu0ny9DrAsM2xLm2hUtSKyhlwZgs5omWzuDMLfp3fLgCtz3co3uLPVdK8NhEsZUJjnsFrkqRpqRdB_HkQuitshVTeZRG3RFp0u8dl-Uc0ckTahD1jf_i9HjdMf4V7f6ZtHnBCw5v_s_rdwtutLE3e9soy23YcuUd2Dloswvuwg80lk2NVaZLy-YLokKvX2eedZmXrMK-uILTik1LhuEzOxwxjkCktY5eMc2sa03xOQoTe28n2FJ8s0l7M411aY9soJea4ol7cHgpC3AftstZ6R4CM1orZfoF9y4TMtXKxzbFkdEzyoJbE8AeoiSfNyQkeb15S_o5gSknMOUNmALodTDKTUvzTtVGTjb0eLnq8e_Rdzt05a2xq_Lf0Arg-aoZzRSdPenSzc5QRkhJXHSSb5ChQ1u6eZkG8KAB-2pCGHimxJsUgFxTg5UA0aSvt5TTLzVdeqKUwjj80eapP4Md1If84_549Biu408WzYe2XdheLs7cE7hmzpfTavG0VnMGny9bL34BPVaSqg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Incidence+and+prevalence+of+multiple+sclerosis+in+the+UK+1990-2010%3A+a+descriptive+study+in+the+General+Practice+Research+Database&rft.jtitle=Journal+of+neurology%2C+neurosurgery+and+psychiatry&rft.au=Mackenzie%2C+I+S&rft.au=Morant%2C+S+V&rft.au=Bloomfield%2C+G+A&rft.au=MacDonald%2C+T+M&rft.date=2014-01-01&rft.issn=1468-330X&rft.eissn=1468-330X&rft.volume=85&rft.issue=1&rft.spage=76&rft_id=info:doi/10.1136%2Fjnnp-2013-305450&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3050&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3050&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3050&client=summon